ProPhase Labs Inc (PRPH)

2.25
0.03 1.30
NASDAQ : Health Care
Prev Close 2.28
Open 2.28
Day Low/High 2.26 / 2.28
52 Wk Low/High 1.05 / 1.85
Volume 9.57K
Avg Volume 15.10K
Exchange NASDAQ
Shares Outstanding 16.17M
Market Cap 36.86M
EPS -0.20
P/E Ratio 2.68
Div & Yield N.A. (N.A)

Latest News

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ARL, DXPE, KT, PRPH, TAIT, TI.A Downgrades: APC, DKS, VCO Initiations: NBEV Read on to get TheStreet Quant Ratings' detailed report:

Ratings Changes Today

Upgrades: CTCM, NAT, TTPH, UAM, XOXO Downgrades: ISLE, PRPH, WIFI Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

4 Stocks Under $10 Moving Higher

4 Stocks Under $10 Moving Higher

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Stocks Finish Near Session Lows

Stocks Finish Near Session Lows

The major U.S. equity averages sink on fresh concerns about global economic growth and trepidation about third-quarter earnings season.

Stock Futures Waver Ahead of Earnings Kickoff

Stock Futures Waver Ahead of Earnings Kickoff

U.S. stock futures are waffling Tuesday ahead of third-quarter earnings season.

CEO Fought His Way In to Lead Battle Vs. Colds

CEO Fought His Way In to Lead Battle Vs. Colds

The maker of Cold-EEZE lozenges says being a good chief executive means relying on good employees.

TheStreet Quant Rating: C (Hold)